# Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients

> **NCT00384904** · PHASE4 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 40 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Atazanavir/Ritonavir
- **DRUG:** Atazanavir/Ritonavir + Famotidine
- **DRUG:** Atazanavir/Ritonavir + Famotidine
- **DRUG:** Atazanavir/Ritonavir
- **DRUG:** Atazanavir/Ritonavir + Tenofovir Disproxil Fumrarate + Famotidine
- **DRUG:** Atazanavir/Ritonavir + Tenofovir Disproxil Fumrarate + Famotidine

## Key facts

- **NCT ID:** NCT00384904
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2010-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00384904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00384904, "Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00384904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*